Management of Antithrombotic Therapy for Gastroenterological Endoscopy from a Cardio-Cerebrovascular Physician's Point of View
Clinical Endoscopy
;
: 320-323, 2014.
Article
in English
| WPRIM
| ID: wpr-108892
ABSTRACT
Periprocedural management of antithrombotics for gastroenterological endoscopy is a common clinical issue. To decide how to manage the use of antithrombotics in patients undergoing endoscopy, the risk for hemorrhage and thromboembolism during the procedure must be considered. For low-risk procedures, no adjustments in antithrombotics are needed. For high-risk procedures with a low thromboembolic risk, discontinuation of warfarin at 5 days, and clopidogrel at 5 to 7 days before the procedure has been recommended. However, it is better to continue aspirin use even during high-risk procedures. A heparin bridging therapy may be considered before endoscopy in patients with a high thromboembolic risk. The management of patients taking antithrombotics remains complex, especially in high-risk settings.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thromboembolism
/
Warfarin
/
Heparin
/
Aspirin
/
Endoscopy
/
Hemorrhage
Limits:
Humans
Language:
English
Journal:
Clinical Endoscopy
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS